Panel Recording on 6.11: Accessing Capital in the Time of COVID CATEGORIES Asian Capabilities Capital Raising Commercial Assessment Locust Walk […]
Panel Recording on 5.7: Biopharma Deal Maker’s Guide to Strategic Partnerships CATEGORIES Asian Capabilities Capital Raising Commercial Assessment Locust Walk
Panel Recording on 4.16: Q1 2020 Biopharma Market Conditions Live Panel CATEGORIES Asian Capabilities Capital Raising Commercial Assessment Locust Walk
Q1 2020 Biopharma Report Each quarter, Locust Walk deal team members compile key statistics and trends on strategic transactions and
LIVE Panel Discussion: Q1 2020 Biopharma Market Conditions CATEGORIES Asian Capabilities Capital Raising Commercial Assessment Locust Walk Institute Market Trends
Panel Recording on 4.2: Strategic Implications of COVID-19 on Biopharma Companies & Investors CATEGORIES Asian Capabilities Capital Raising Commercial Assessment
LIVE Panel Discussion, COVID-19: Strategic Implications on Biopharma CATEGORIES Asian Capabilities Capital Raising Commercial Assessment Locust Walk Institute Market Trends
Strategic Implications of COVID-19 on Biopharma CATEGORIES Asian Capabilities Capital Raising Commercial Assessment Locust Walk Institute Market Trends Negotiation Partnering
Deal Theory In the summer of 2019, Locust Walk launched a blog post, Financing overhang or hangover: The impact on partnerships
Deal Makers of Japan Locust Walk has been active in Asia, in particular, Japan for nearly half of the firm’s